nonalcoholic fatty liver disease treatment

Authors

m sadeghian pediatric gastroenterologist, division of gastroenterology, department of pediatrics, aliasghar hospital, tehran university of medical sciences, tehran, iran.

a torabi medical student, tehran university of medical sciences, tehran, iran. iran tehran university markaze tebi hospital pediatrics ward.

abstract

nonalcoholic fatty liver disease (nafld) is increasing in pediatric age group parallel to the growing prevalence of obesity and overweight all around the world. so changing in life style and   interventions on obesogenic environment is cornerstone of nafld therapy in obese children. some experts recommend that children and adolescents be encouraged to follow a low-fat, low-glycemic-index diet that includes eating a minimum of 5 servings of vegetables and fruits daily, engaging in physical activity for at least 1 hour daily, and minimizing television/computer time to 2 hours daily.  in spite of effectiveness of weight loss and exercise in improvement nafld, this goal is very difficult to be achieved and pharmacological approaches have become necessary. pharmacologic therapies against one or more specific factors and/or molecules involved in the development of nafld (i.e., insulin resistance, free fatty acid lipid toxicity, and oxidative stress) also might slow the progression of nafld to nash or cirrhosis.  on this basis, insulin sensitizers, antioxidants, cytoprotective agents, and dietary supplementations have been evaluated in pediatric clinical trials but there is no approved pharmacologic therapy for nafld or nash. not all obese children affected by nafld. diet modification and regular exercise beside to serial medical follow up highly suggested for this group of children. normal weight and thin children with nafld or nash should be investigated appropriately in a logical manner based on causes of primary liver steatosis in children and treatment of underlying disease can cause improvement fatty liver in these patients.   keywords: non-alcoholic fatty liver disease; non-alcoholic steatohepatitis; children; steatosis; treatment

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Nonalcoholic Fatty Liver Disease Treatment

Nonalcoholic fatty liver disease (NAFLD) is increasing in pediatric age group parallel to the growing prevalence of obesity and overweight all around the world. So changing in life style and   interventions on obesogenic environment is cornerstone of NAFLD therapy in obese children. Some experts recommend that children and adolescents be encouraged to follow a low-fat, low-glycemic-index diet t...

full text

Antioxidant treatment in nonalcoholic fatty liver disease.

Vitamin E is one of the most important lipid-soluble antioxidants, and it prevents lipid peroxidation and scavenges free radicals. As oxidative stress takes a role in the pathogenesis of nonalcoholic steatohepatitis (NASH), vitamin E supplementation acts as a promising therapeutic strategy. In a phase 3, multicenter, randomized, placebo-controlled, double-blind clinical trial (PIVENS) by Sanyal...

full text

Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) is known to be associated with an increased risk of colorectal cancer (CRC). However, the relationship between NAFLD and the prognosis of CRC remains unclear. The primary objective of this study was to evaluate the overall survival (OS) and disease-free survival (DFS) rates in patients with CRC and the secondary objective was to compare clinicopathologic...

full text

Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (or NAFLD) is a recently recognized chron­ ic liver disease, strongly linked to obesity. As the number of obese Americans has doubled in the past three decades, not sur­ prisingly, NAFLD is becoming increasingly common. The hallmark of persons with NAFLD is having too much fat in the liver. This fat is deposited within the cells of the liver (the medical term is...

full text

Nonalcoholic fatty liver disease.

N 'onalcoholic fatty liver disease (NAFLD) includes a spectrum of hepatic pathology that resembles alcohol-induced liver disease but develops in individuals who are not heavy drinkers. NAFLD is likely to be the most common cause of chronic liver disease in many countries and may also potentiate liver damage induced by other agents, such as alcohol, industrial toxins, and hepatotrophic viruses. ...

full text

Nonalcoholic fatty liver disease.

Nonalcoholic fatty liver disease (NAFLD) refers to the presence of hepatic steatosis not associated with a significant intake of ethanol. Insulin resistance is central to the pathogenesis of NAFLD; thus obesity, diabetes, and the metabolic syndrome are frequently associated with the disease. Consequently, as these metabolic conditions emerge as major health problems in Western society, it is no...

full text

My Resources

Save resource for easier access later


Journal title:
international journal of pediatrics

جلد ۲، شماره ۲.۱، صفحات ۶۳-۶۳

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023